List of Tables
Table 1. Global End-Stage Renal Disease (ESRD) Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global End-Stage Renal Disease (ESRD) Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global End-Stage Renal Disease (ESRD) Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market End-Stage Renal Disease (ESRD) Drugs Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of End-Stage Renal Disease (ESRD) Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of End-Stage Renal Disease (ESRD) Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of End-Stage Renal Disease (ESRD) Drugs, Product Type & Application
Table 12. Global Key Manufacturers of End-Stage Renal Disease (ESRD) Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global End-Stage Renal Disease (ESRD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global End-Stage Renal Disease (ESRD) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2018-2023) & (K Pcs)
Table 18. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2018-2023)
Table 19. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2024-2029) & (K Pcs)
Table 20. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2024-2029)
Table 21. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 27. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 28. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 33. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2024-2029) & (K Pcs)
Table 38. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 43. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 48. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2018-2023)
Table 51. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2024-2029)
Table 52. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2018-2023)
Table 53. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2024-2029)
Table 54. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Type (2018-2023)
Table 59. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Type (2024-2029)
Table 60. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Application (2018-2023)
Table 61. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Application (2024-2029)
Table 62. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2018-2023)
Table 63. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2024-2029)
Table 64. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Application (2018-2023)
Table 69. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Application (2024-2029)
Table 70. CTI BioPharma Corp Corporation Information
Table 71. CTI BioPharma Corp Description and Business Overview
Table 72. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product
Table 74. CTI BioPharma Corp Recent Developments/Updates
Table 75. Merck & Co Inc Corporation Information
Table 76. Merck & Co Inc Description and Business Overview
Table 77. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product
Table 79. Merck & Co Inc Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Novartis AG End-Stage Renal Disease (ESRD) Drugs Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Prolong Pharmaceuticals LLC Corporation Information
Table 86. Prolong Pharmaceuticals LLC Description and Business Overview
Table 87. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product
Table 89. Prolong Pharmaceuticals LLC Recent Developments/Updates
Table 90. VESSL Therapeutics Ltd Corporation Information
Table 91. VESSL Therapeutics Ltd Description and Business Overview
Table 92. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product
Table 94. VESSL Therapeutics Ltd Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. End-Stage Renal Disease (ESRD) Drugs Distributors List
Table 98. End-Stage Renal Disease (ESRD) Drugs Customers List
Table 99. End-Stage Renal Disease (ESRD) Drugs Market Trends
Table 100. End-Stage Renal Disease (ESRD) Drugs Market Drivers
Table 101. End-Stage Renal Disease (ESRD) Drugs Market Challenges
Table 102. End-Stage Renal Disease (ESRD) Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of End-Stage Renal Disease (ESRD) Drugs
Figure 2. Global End-Stage Renal Disease (ESRD) Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Type in 2022 & 2029
Figure 4. Calcium Succinate Product Picture
Figure 5. Mk-3866 Product Picture
Figure 6. Pacritinib Product Picture
Figure 7. Sanguinate Product Picture
Figure 8. Tesidolumab Product Picture
Figure 9. Others Product Picture
Figure 10. Global End-Stage Renal Disease (ESRD) Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Clinic
Figure 14. ICU
Figure 15. Others
Figure 16. Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global End-Stage Renal Disease (ESRD) Drugs Market Size (2018-2029) & (US$ Million)
Figure 18. Global End-Stage Renal Disease (ESRD) Drugs Sales (2018-2029) & (K Pcs)
Figure 19. Global End-Stage Renal Disease (ESRD) Drugs Average Price (USD/Pcs) & (2018-2029)
Figure 20. End-Stage Renal Disease (ESRD) Drugs Report Years Considered
Figure 21. End-Stage Renal Disease (ESRD) Drugs Sales Share by Manufacturers in 2022
Figure 22. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest End-Stage Renal Disease (ESRD) Drugs Players: Market Share by Revenue in 2022
Figure 24. End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global End-Stage Renal Disease (ESRD) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2018-2029)
Figure 27. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2018-2029)
Figure 28. U.S. End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2018-2029)
Figure 31. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2018-2029)
Figure 32. Germany End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2018-2029)
Figure 39. China End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Taiwan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Philippines End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2018-2029)
Figure 50. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2018-2029)
Figure 51. Mexico End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2018-2029)
Figure 56. Turkey End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of End-Stage Renal Disease (ESRD) Drugs by Type (2018-2029)
Figure 60. Global Revenue Market Share of End-Stage Renal Disease (ESRD) Drugs by Type (2018-2029)
Figure 61. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Type (2018-2029)
Figure 62. Global Sales Market Share of End-Stage Renal Disease (ESRD) Drugs by Application (2018-2029)
Figure 63. Global Revenue Market Share of End-Stage Renal Disease (ESRD) Drugs by Application (2018-2029)
Figure 64. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Application (2018-2029)
Figure 65. End-Stage Renal Disease (ESRD) Drugs Value Chain
Figure 66. End-Stage Renal Disease (ESRD) Drugs Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed